ICURE

ICURE Pharmaceutical Inc. is a biopharmaceutical company uniquely positioned to lead advances in Transdermal Drug Delivery Technology. ICURE is applying its advanced transdermal delivery technology into pharmaceutical and dermo-cosmetic patches. The core business of ICURE is based on ‘Cure & Care’ solution through the skin. ICURE is actively producing NSAIDS patches in Asian countries. ICURE is also producing systemic patches, such as nicotine and rivastigmine patches, and developing other innovative patch products, like Donepezil patches, in its R&D Center. ICURE’s goal is to be a global leader in transdermal patch manufacturer for both patch and plaster products. Currently, ICURE is targeting to develop patch mediation for CNS disease in priority with higher compliance and less side effects than existing medication.

Along with pharmaceutical business, ICURE has its own cosmetic brand, MEDITIME. By incorporating TDDS technology into cosmetic products, MEDITIME products are mainly for skin care and anti-aging. ICURE’s unique TDDS technology allows the act...